Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $35.9750 (-0.81%) ($35.9750 - $36.1500) on Fri. Jun. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 60 | Latest Price | $35.9750(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.8% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.035% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-12%) TBT(-6%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $36.16(-0.51%) | 10 Day Moving Average | $36.29(-0.87%) | 20 Day Moving Average | $35.18(2.26%) | To recent high | -25.6% | To recent low | 14.8% | Market Cap | $2.234b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |